Current Issue June 2012, Vol. 39, No. 6

Issue Highlights

Reviews

  • Cytosine deoxyribonucleoside anti-HIV analogues: a small chemical substitution allows relevant activities
    June 2012(Vol. 39 | No. 6 | Pages 458-463)

    Francesco Scaglione, Liberato Berrino

  • Invasive fungal infections in patients with cancer in the Intensive Care Unit
    June 2012(Vol. 39 | No. 6 | Pages 464-471)

    Nikolaos V. Sipsas, Dimitrios P. Kontoyiannis

Full length articles

  • Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii
    June 2012(Vol. 39 | No. 6 | Pages 472-477)

    Felipe Fernández Cuenca, Mª del Carmen Gómez Sánchez, Francisco Javier Caballero-Moyano, Jordi Vila, Luis Martínez-Martínez, Germán Bou, Jesús Rodríguez Baño, Alvaro Pascual

  • Oseltamivir-resistant influenza A(H1N1) 2009 virus in Greece during the post-pandemic 2010–2011 season
    16 May 2012

    Afroditi Kourti, Grecory Spanakos, Leda Politi, Anastasia Stavropoulou, Nicholas Spanakis, Athanassios Tsakris

  • Impact of an antimicrobial stewardship programme on patient safety in Singapore General Hospital
    16 May 2012

    Yi Xin Liew, Winnie Lee, Joan Chain Zhu Loh, Yiying Cai, Sarah Si Lin Tang, Cheryl Li Ling Lim, Jocelyn Teo, Rachel Wen Qin Ong, Andrea Lay-Hoon Kwa, Maciej Piotr Chlebicki

  • Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi
    16 May 2012

    Phercyles Veiga-Santos, Emile S. Barrias, Júlio F.C. Santos, Thiago Luiz de Barros Moreira, Tecia Maria Ulisses de Carvalho, Julio A. Urbina, Wanderley de Souza

  • Corrigendum to “Potential protective role of linezolid against Clostridium difficile infection” [Int. J. Antimicrob. Agents. 39(5) (2012) 414–419]
    14 May 2012

    Maricela Valerio, Miguel Pedromingo, Patricia Mũnoz, Luis Alcalá, Mercedes Marin, Teresa Peláez, Maddalena Giannella, Emilio Bouza

  • Emergence of blaOXA-23 and blaOXA-58 carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria
    14 May 2012

    Meriem Touati, Seydina M. Diene, Abdelkarim Racherache, Mazouz Dekhil, Abdelghani Djahoudi, Jean-Marc Rolain

  • View More Articles in Press...

On the Cover

Cover Image

Journal Access

Full-text articles are available from 1995 to the present. Access to abstracts is complimentary. Access to full text is limited to print subscribers. Register or login to:

Buy a Subscription Now

Activate Online Access

Publishing Information

International Journal of Antimicrobial Agents is published by Elsevier for the International Society of Chemotherapy (ISC) for Infection and Cancer.

Elsevier

Access this journal onSciVerse ScienceDirect
Print or Share This Page

About International Journal of Antimicrobial Agents

International Journal of Antimicrobial Agents provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents (antiviral agents, antiparasitic agents, antibacterial agents, antifungal agents, immunotherapeutic agents, etc.). In addition, the journal signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents, immunomodulators and immunotherapy. Special attention is given to articles providing insight into the problems of antimicrobial resistance, local as well as world-wide, both in the hospital and in the community. Papers on the underlying mechanisms and on immunomodulating agents are also welcome. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.

ISC Information

The general objectives of the International Society of Chemotherapy (ISC) for Infection and Cancer are to advance the education and science of chemotherapy. International congresses and conferences promoting the development of chemotherapy are held regularly. The ISC encourages, supports and sponsors the formation of international working groups for special research projects, commissions, training projects and the use of chemotherapeutics in the field of antimicrobial and antineoplastic chemotherapy. It also helps to co-ordinate the activities of these working groups.